Paul W. Jungnickel
Auburn University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul W. Jungnickel.
Journal of General Internal Medicine | 1997
Paul W. Jungnickel; Pierre A. Maloley; Elton L. Vander Tuin; Tom E. Peddicord; James R. Campbell
ObjectiveTo compare the effects of pretreatment with two aspirin regimens and placebo on niacin-induced cutaneous reactions.DesignRandomized, double-blind, placebo-controlled, crossover study.SettingInternal medicine clinic in an academic health center.ParticipantsForty-two healthy subjects (22 males and 20 females) between the ages of 35 and 65 (mean age 44.2 years) were recruited and completed the study. Subjects received aspirin 325 mg, aspirin 650 mg, and placebo for 4 consecutive days, and on the fourth day also ingested 500 mg of immediate-release niacin 30 minutes after taking aspirin or placebo. They reported the intensity of flushing, headache, pruritus, tingling, and warmth on a 10-cm visual analogue scale. Reactions were evaluated at time 0 (before the niacin, dose), and at 15, 30, 60, and 120 minutes following the niacin dose. Cutaneous reactions were compared at each evaluation time and scored by two other methods. The peak intensity was the highest score recorded at any of the four evaluation times after niacin administration. An intensity-time factor was calculated by totaling the scores of each of the four evaluation times.Measurement and Main ResultsThe symptom scores for flushing, itching, tingling, and warmth were all significantly reduced by both aspirin regimens (p<.05 in all cases), although there were no significant differences between the 325-mg and 650-mg doses. The results were similar for each scoring method.ConclusionsAn aspirin regimen of 325 mg is effective in suppressing niacin-induced cutaneous reactions. Increasing the dose to 650 mg does not provide additional benefit.
The American Journal of Pharmaceutical Education | 2016
Emily K. Dornblaser; Anna Ratka; Shaun E. Gleason; David Ombengi; Toyin Tofade; Patricia R. Wigle; Antonia Zapantis; Melody Ryan; Sharon E. Connor; Lauren J. Jonkman; Leslie Ochs; Paul W. Jungnickel; Jeanine P. Abrons; Naser Z. Alsharif
The objective of this article is to describe the key areas of consideration for global/international advanced pharmacy practice experience (G/I APPE) preceptors, students and learning objectives. At the 2013 Annual Meeting of the American Association of Colleges of Pharmacy (AACP), the GPE SIG prepared and presented an initial report on the G/IAPPE initiatives. Round table discussions were conducted at the 2014 AACP Annual Meeting to document GPE SIG member input on key areas in the report. Literature search of PubMed, Google Scholar and EMBASE with keywords was conducted to expand this report. In this paper, considerations related to preceptors and students and learning outcomes are described. Preceptors for G/I APPEs may vary based on the learning outcomes of the experience. Student learning outcomes for G/I APPEs may vary based on the type of experiential site. Recommendations and future directions for development of G/IAPPEs are presented. Development of a successful G/I APPE requires significant planning and consideration of appropriate qualifications for preceptors and students.
The American Journal of Pharmaceutical Education | 2014
Wesley Oliver; Grant McGuffey; Salisa C. Westrick; Paul W. Jungnickel; Christopher J. Correia
Objective. To identify reasons for drinking, determine the patterns of alcohol abuse, and explore relationships between drinking motives and alcohol abuse patterns in pharmacy students. Methods. A cross-sectional anonymous, voluntary, self-administered paper survey instrument was administered to first-year (P1) through third-year (P3) pharmacy students as part of a professional seminar. Results. Survey instruments were completed by 349 pharmacy students (95.9% cooperation rate). Using the Alcohol Use Disorders Identification Test criteria, 23.2% of students reported hazardous or harmful use and 67.2% of students reported consuming alcohol at hazardous levels during the past year. Students who were male (37.0%), single (25.3%), and attended the main campus (26.2%) were more likely than their counterparts to report hazardous or harmful alcohol use. Pharmacy students reported social motives as the most common reason for drinking; however, coping and enhancement motives were more predictive of harmful or hazardous alcohol use. Conclusion. Approximately 1 in 4 pharmacy students (23%) reported hazardous or harmful alcohol use. Education about the dangers of alcohol abuse and intervention programs from colleges and schools of pharmacy are recommended to help address this issue.
The American Journal of Pharmaceutical Education | 2015
Megan L. Zeek; Matthew J. Savoie; Matthew Song; Leanna M. Kennemur; Jingjing Qian; Paul W. Jungnickel; Salisa C. Westrick
Objective. To identify sleep patterns and frequency of daytime sleepiness and to assess the association between sleep duration and academic performance among student pharmacists. Methods. A cross-sectional design was used. An anonymous self-administered paper questionnaire was administered to first-year through third-year students at a pharmacy school. Results. Questionnaires were completed by 364 student pharmacists (79.4% response rate and 93.8% cooperation rate). More than half of student pharmacists obtained less than 7 hours of sleep at night during a typical school week (54.7%) and a large majority on the night prior to an examination (81.7%). Almost half (47.8%) felt daytime sleepiness almost every day. Longer sleep duration the night prior to an examination was associated with higher course grades and semester grade point averages (GPAs). Conclusion. A majority of student pharmacists had suboptimal durations of sleep, defined as fewer than 7 hours. Adequate sleep the night prior to an examination was positively associated with student course grades and semester GPAs.
The American Journal of Pharmaceutical Education | 2009
Paul W. Jungnickel; Kristi W. Kelley; Dana P. Hammer; Stuart T. Haines; Karen F. Marlowe
The American Journal of Pharmaceutical Education | 1997
Paul W. Jungnickel
The American Journal of Pharmaceutical Education | 2004
Bruce A. Berger; Stephen L. Butler; Wendy Duncan-Hewitt; Bill G. Felkey; Paul W. Jungnickel; Janelle Krueger; Charles R. Perry; Charles T. Taylor
The American Journal of Pharmaceutical Education | 2010
Paul W. Jungnickel; Edward M. DeSimone; Julie C. Kissack; Lisa A. Lawson; Matthew M. Murawski; Brandon J. Patterson; Raylene M. Rospond; David M. Scott; Jennifer Athay
The American Journal of Pharmaceutical Education | 2007
Wendy Duncan-Hewitt; Paul W. Jungnickel; R. Lee Evans
Journal of The American Pharmaceutical Association | 1997
Paul W. Jungnickel; Darcy A. Wisehart